Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.36B |
| 2 |
Tesla
TSLA
|
+$984M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$662M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$575M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$574M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.05B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$505M |
| 3 |
Amazon
AMZN
|
+$473M |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$439M |
| 5 |
iShares Core MSCI Europe ETF
IEUR
|
+$346M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.23% |
| 2 | Consumer Discretionary | 2.03% |
| 3 | Financials | 1.67% |
| 4 | Communication Services | 1.15% |
| 5 | Healthcare | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REV
8651
DELISTED
Revlon, Inc.
REV
| $84K | ﹤0.01% |
16,149
-119,788
| -88% | -$778K |
|
8652
BlackRock Income Trust
BKT
$341M
| $83K | ﹤0.01% |
6,700
-31,464
| -82% | -$428K |
|
8653
Broadwind
BWEN
$109M
| $83K | ﹤0.01% |
+27,573
| New | +$70.3K |
|
8654
Lexicon Pharmaceuticals
LXRX
$1.1B
| $83K | ﹤0.01% |
+34,541
| New | +$95.6K |
|
8655
MannKind Corp
MNKD
$1.32B
| $83K | ﹤0.01% |
26,949
-102,143
| -79% | -$385K |
|
8656
PUT
The Honest Company
HNST
$586M
| $82K | ﹤0.01% |
23,500
-4,200
| -15% | -$15.4K |
|
8657
Protalix BioTherapeutics
PLX
$198M
| $82K | ﹤0.01% |
78,476
-5,080
| -6% | -$5.63K |
|
8658
Wheels Up
UP
$198M
| $82K | ﹤0.01% |
356
+289
| +431% | +$116K |
|
|
ICVX
8659
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $82K | ﹤0.01% |
+25,928
| New | +$162K |
|
|
OPALW
8660
DELISTED
OPAL Fuels Inc. Warrant
OPALW
| $82K | ﹤0.01% |
+56,704
| New | +$77K |
|
8661
Archrock
AROC
$5.8B
| $81K | ﹤0.01% |
12,674
-10,807
| -46% | -$82.4K |
|
8662
PUT
iHeartMedia
IHRT
$583M
| $81K | ﹤0.01% |
+11,100
| New | +$96K |
|
8663
Incannex Healthcare
IXHL
$37.7M
| $81K | ﹤0.01% |
+154
| New | +$80.6K |
|
8664
Karyopharm Therapeutics
KPTI
$48M
| $81K | ﹤0.01% |
985
-12,921
| -93% | -$965K |
|
|
MONDW
8665
DELISTED
Mondee Holdings, Inc. Warrant
MONDW
| $81K | ﹤0.01% |
126,160
+1,160
| +0.9% | +$507 |
|
8666
Context Therapeutics
CNTX
$44.5M
| $80K | ﹤0.01% |
+72,060
| New | +$130K |
|
|
ETW
8667
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| $80K | ﹤0.01% |
+10,627
| New | +$93K |
|
|
GATO
8668
PUT
DELISTED
Gatos Silver, Inc.
GATO
| $80K | ﹤0.01% |
29,700
-5,300
| -15% | -$16.6K |
|
8669
Diamondrock Hospitality Co
DRH
$2.56B
| $79K | ﹤0.01% |
10,558
-42,183
| -80% | -$372K |
|
8670
Zevia
ZVIA
$111M
| $79K | ﹤0.01% |
+18,265
| New | +$74.4K |
|
|
ROIVW
8671
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
| $79K | ﹤0.01% |
202,089
-586
| -0.3% | -$312 |
|
8672
PUT
B2Gold
BTG
$6.64B
| $78K | ﹤0.01% |
24,100
-72,000
| -75% | -$237K |
|
8673
Ranpak Holdings
PACK
$473M
| $78K | ﹤0.01% |
22,749
+11,771
| +107% | +$64.7K |
|
|
SABA
8674
Saba Capital Income & Opportunities Fund II
SABA
$223M
| $78K | ﹤0.01% |
+9,546
| New | +$86.4K |
|
8675
Stagwell
STGW
$2.24B
| $78K | ﹤0.01% |
11,173
-12,648
| -53% | -$81.6K |
|
Similar funds
Jane Street's Q3 2022 Portfolio in Review
As of Q3 2022, Jane Street held 11,057 positions worth $229B, down 3.1% from $236B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Jane Street's Q3 2022 filing shows 1,520 new, 3,775 increased, 4,205 reduced and 1,444 closed positions. Its largest new stake was iShares Gold Trust: 8,373,079 shares worth $264M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.05B.
By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jane Street's largest Q3 2022 buy was iShares Gold Trust: 8,373,079 shares worth $264M.
- Jane Street added most to Invesco QQQ Trust in Q3 2022, an estimated $1.36B increase.
- Jane Street's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.05B.
- Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2022, selling an estimated $187M.
- Jane Street's ten largest holdings make up 35% of its $229B portfolio in Q3 2022.
- Jane Street opened 1,520 new positions and closed 1,444 in Q3 2022.
- Jane Street's portfolio value fell 3.1% quarter-over-quarter to $229B.
Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.